Emma Walmsley

Emma Walmsley
Name	Emma Walmsley
Birth date	1 June 1969
Birth place	Barnton, Cheshire, England
Education	University of Oxford (BA)
Occupation	Business executive
Title	Chief Executive Officer, GSK
Term	2017–present
Predecessor	Andrew Witty
Spouse	David Owen

Emma Walmsley is a British business executive who has served as the chief executive officer of the pharmaceutical and biotechnology company GlaxoSmithKline (GSK) since 2017. She is the first woman to lead a major pharmaceutical firm and was previously the chief executive of GSK Consumer Healthcare. Walmsley's tenure has focused on reshaping GSK's research and development pipeline, executing a major consumer health demerger, and navigating significant challenges including the COVID-19 pandemic.

Early life and education

Emma Walmsley was born in Barnton, Cheshire, and spent part of her childhood in East Asia, including Hong Kong. She was educated at the all-girls Ursuline High School in Wimbledon. She subsequently read Classics at Oxford University, attending St Hugh's College and graduating with a Bachelor of Arts degree. Before entering the corporate world, she briefly worked as a teacher in Shanghai.

Career at L'Oréal

Walmsley began her business career in 1995 at the French cosmetics giant L'Oréal, joining its U.S. division. She held various marketing and general management roles across the company's portfolio of brands in both Paris and New York City. Her responsibilities included working on major consumer brands such as Garnier and Maybelline, where she gained extensive experience in brand building, innovation, and international markets. She spent 17 years at L'Oréal, ultimately rising to the position of General Manager for L'Oréal China, based in Shanghai.

Tenure at GlaxoSmithKline and GSK

In 2010, Walmsley joined GlaxoSmithKline to lead its global consumer healthcare division, overseeing brands like Sensodyne, Panadol, and Nicorette. She was appointed to the GSK Corporate Executive Team in 2011. In 2015, she became the Chief Executive Officer of GSK Consumer Healthcare, a joint venture with Novartis. Following the announcement by then-CEO Andrew Witty to step down, Walmsley was named his successor in 2017, taking the helm of the entire FTSE 100 company. Key events during her tenure include the demerger of Haleon in 2022, the acquisition of Tesaro and collaboration with German firm CureVac, and navigating the company's role in developing COVID-19 treatments and vaccines. She has also overseen a significant restructuring of GSK's research and development organization under leaders like Hal Barron.

Leadership and business strategy

Walmsley's strategic vision for GSK has centered on strengthening its pharmaceuticals pipeline, particularly in oncology and immunology, while separating the consumer health business. She executed a major portfolio review, divesting non-core assets and focusing investment on innovative medicines and vaccines. Her leadership during the COVID-19 pandemic involved managing the development of the SARS-CoV-2 antibody treatment Sotrovimab with Vir Biotechnology and the vaccine candidate with Sanofi. She has also emphasized improving company culture and diversity, setting public targets for gender and ethnic representation within GSK's senior leadership.

Recognition and awards

Walmsley has been frequently listed among the world's most powerful women in business by publications such as Forbes and Fortune. She was appointed a Commander of the Order of the British Empire (CBE) in the 2021 Birthday Honours for services to the pharmaceutical industry and business. She has also been recognized by the BBC's 100 Women list and has received honorary doctorates from institutions including the University of Bath.

Personal life

Emma Walmsley is married to David Owen, a former Diageo executive. The couple has four children and resides in London. She is known to be a private individual but has spoken publicly about the challenges of balancing a high-profile corporate career with family life. She serves as a non-executive director on the board of Microsoft and is a member of the Pfizer board of directors.

Category:1969 births Category:Living people Category:British businesswomen Category:Chief executives in the pharmaceutical industry Category:People educated at Ursuline High School, Wimbledon Category:Alumni of St Hugh's College, Oxford Category:Commanders of the Order of the British Empire